HomeNUZ • ASX
add
Neurizon Therapeutics Ltd
Previous close
$0.083
Day range
$0.083 - $0.083
Year range
$0.079 - $0.18
Market cap
56.70M AUD
Avg Volume
50.60K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.99M | 290.03% |
Operating expense | 5.70M | 26.25% |
Net income | -2.77M | 23.94% |
Net profit margin | -92.70 | 80.50% |
Earnings per share | — | — |
EBITDA | -2.72M | 27.59% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.95M | -21.43% |
Total assets | 15.34M | -1.24% |
Total liabilities | 7.05M | 94.69% |
Total equity | 8.29M | — |
Shares outstanding | 535.79M | — |
Price to book | 4.15 | — |
Return on assets | -44.29% | — |
Return on capital | -68.58% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.77M | 23.94% |
Cash from operations | -4.25M | -59.14% |
Cash from investing | -2.75K | 99.82% |
Cash from financing | 6.14M | 40.08% |
Net change in cash | 1.88M | 842.23% |
Free cash flow | -1.56M | 30.85% |
About
Founded
2000
Website
Employees
52
